# Pancreatic Enzyme Suppletion in Pancreatic Cancer

> **NCT01401387** · PHASE4 · WITHDRAWN · sponsor: **Foundation for Liver Research**

## Conditions studied

- Adenocarcinoma of the Pancreas
- Normal Pancreatic Exocrine Function

## Interventions

- **OTHER:** Timing of start treatment with pancreatic enzymes
- **OTHER:** Timing of start treatment with pancreatic enzymes

## Key facts

- **NCT ID:** NCT01401387
- **Lead sponsor:** Foundation for Liver Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-10
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study never started
- **Last updated:** 2013-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01401387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01401387, "Pancreatic Enzyme Suppletion in Pancreatic Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01401387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*